Focus Financial Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
2,324
+718
+45% +$97.1K 0.01% 569
2026
Q1
$205K Sell
1,606
-190
-11% -$23.7K 0.01% 699
2025
Q4
$219K Buy
+1,796
New +$206K 0.01% 679
2024
Q4
Sell
-2,207
Closed -$218K 710
2024
Q3
$218K Buy
+2,207
New +$217K 0.01% 626
2021
Q1
Sell
-2,093
Closed -$295K 559
2020
Q4
$295K Buy
2,093
+53
+3% +$6.79K 0.03% 350
2020
Q3
$227K Sell
2,040
-262
-11% -$29.4K 0.02% 395
2020
Q2
$258K Sell
2,302
-374
-14% -$36.8K 0.03% 331
2020
Q1
$207K Buy
2,676
+125
+5% +$11.1K 0.03% 338
2019
Q4
$243K Sell
2,551
-365
-13% -$31.6K 0.03% 359
2019
Q3
$222K Buy
2,916
+342
+13% +$28.4K 0.03% 352
2019
Q2
$226K Sell
2,574
-100
-4% -$8.53K 0.03% 333
2019
Q1
$242K Buy
+2,674
New +$227K 0.04% 318

Other funds holding XBI

Focus Financial Network's XBI Position: Q2 2026 in Review

Focus Financial Network increased its State Street SPDR S&P Biotech ETF (XBI) stake by 45% in Q2 2026, buying an estimated $97.1K and bringing the position to 2,324 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #569.

Focus Financial Network first reported a position in XBI in Q1 2019 and has held it in 12 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Focus Financial Network held 2,324 shares of State Street SPDR S&P Biotech ETF worth $368K as of Q2 2026.
  • Focus Financial Network bought 718 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $97.1K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Focus Financial Network's portfolio in Q2 2026, its #569 holding.
  • Focus Financial Network first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 12 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.